Potential benefit to response rates from trastuzumab added to perioperative chemotherapy for patients with HER-2+ GC

The iCCaRE Consortium for Black Men - Addressing the disproportionate burden of prostate cancer

Selinexor, bortezomib and dexamethasone shows PFS benefit for multiple myeloma

Ide-cel significantly prolongs PFS for r/r multiple myeloma versus standard regimens

First-line NALIRIFOX shows improvement in OS and PFS in metastatic pancreatic cancer

Advancing breast cancer treatment in Uganda by improving molecular testing

Somatic mutation profile of breast cancer in Uganda

PHERGain trial ID's early breast cancer cases that benefit from dual HER2 blockade without chemo

AI-derived digital pathology-based biomarker predicts benefit of long-term ADT with RT in localised high-risk prostate cancer

Maximising diagnosis of colon cancer with target screening

Optimising colon cancer care in Nigeria

Current MM diagnosis and treatment strategies